SciELO - Scientific Electronic Library Online

 
vol.25 issue6Comparison of segmental contractility evaluated by transthoracic echocardiogram and cardiac magnetic resonance in patients with acute myocardial infarctionInitial approach to changes in the mediastinum: A review of the radiographic anatomical references author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

Related links

  • On index processCited by Google
  • Have no similar articlesSimilars in SciELO
  • On index processSimilars in Google

Share


Revista Colombiana de Cardiología

Print version ISSN 0120-5633

Abstract

ROMERO, Martín; VASQUEZ, Eliana; ACERO, Germán  and  HUERFANO, Lina. Estimation of the direct costs of coronary events in Colombia. Rev. Colomb. Cardiol. [online]. 2018, vol.25, n.6, pp.373-379. ISSN 0120-5633.  https://doi.org/10.1016/j.rccar.2018.05.010.

Objective:

To estimate the health care costs associated with patients that develop coronary events associated with risk factors (hypertension, diabetes, and hypercholesterolaemia), as well as the cost as regards the time of onset after such event, in the Colombian context.

Methods:

A retrospective, descriptive study was conducted using the Per-capita Payment Unit (UPC) sufficiency databases of two Colombian insurance companies. Patients were identified that presented with a cardiac event during the year 2014, and their medical history was confirmed (risk factors). The rate of presenting with coronary events in the population was established and the reported costs associated with the procedures practiced during a one-year period were extracted. The costs were organised by categories into different time cut-offs from the presentation of the event.

Results:

A total of 2,103 patients were found with coronary events, of which 583 had arterial hypertension, 354 with dyslipidaemia, and 198 patients with diabetes, as medical history. The total average cost a year of the coronary event was (COP$23,454,569.95), with no previously diagnosed risk it was (COP$23,848,023.32), and with a treated medical history it was (COP$17,040,335.95), (COP$22,075,708.19) and (COP$28,825,710.71) for dyslipidaemia, arterial hypertension, and diabetes, respectively.

Conclusions:

A patient without an early diagnosis of cardiovascular diseases or risk factors, on presenting with a coronary event, incurs higher costs in the therapeutic management of the event than one previously diagnosed and receives treatment for it.

Keywords : Acute myocardial infarction; Cost analysis; Diabetes mellitus; Hypertension; Acute coronary syndrome.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )